Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

Introduction Cabotegravir and rilpivirine (CAB+RPV long-acting (LA)) is recommended as a treatment for HIV-1 allowing people living with HIV to receive 2 monthly injectable treatment, rather than daily pills. Providing injectable therapy in a system designed to provide and manage study participants...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Sara Paparini, Vanessa Apea, James Hand, Rachel Phillips, Chloe M Orkin, Jenny Scherzer, Sadna Ullah, Hamzah Z Farooq, Bakita Kasadha, Gill Hilton-Smith, Amber Haley
Format:	Artigo
Język:	Inglês
Wydane:	BMJ Publishing Group 2023-07-01
Seria:	BMJ Open
Dostęp online:	https://bmjopen.bmj.com/content/13/7/e070666.full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!